Have Insiders Sold Quick Heal Technologies Limited (NSE:QUICKHEAL) Shares Recently?

We note that the Quick Heal Technologies Limited (NSE:QUICKHEAL) Head of Research & Development, Bibhuti Kar, recently sold ₹1.0m worth of stock for ₹203 per share. However we note that the sale only shrunk their holding by 10.0%.

Check out our latest analysis for Quick Heal Technologies

The Last 12 Months Of Insider Transactions At Quick Heal Technologies

In the last twelve months, the biggest single sale by an insider was when the insider, Nitin Kulkarni, sold ₹9.7m worth of shares at a price of ₹218 per share. So we know that an insider sold shares at around the present share price of ₹199. While insider selling is a negative, to us, it is more negative if the shares are sold at a lower price. We note that this sale took place at around the current price, so it isn't a major concern, though it's hardly a good sign.

Insiders in Quick Heal Technologies didn't buy any shares in the last year. The chart below shows insider transactions (by companies and individuals) over the last year. By clicking on the graph below, you can see the precise details of each insider transaction!

I will like Quick Heal Technologies better if I see some big insider buys. While we wait, check out this free list of growing companies with considerable, recent, insider buying.

Does Quick Heal Technologies Boast High Insider Ownership?

Looking at the total insider shareholdings in a company can help to inform your view of whether they are well aligned with common shareholders. A high insider ownership often makes company leadership more mindful of shareholder interests. It's great to see that Quick Heal Technologies insiders own 73% of the company, worth about ₹8.4b. This kind of significant ownership by insiders does generally increase the chance that the company is run in the interest of all shareholders.

So What Does This Data Suggest About Quick Heal Technologies Insiders?

Insiders sold Quick Heal Technologies shares recently, but they didn't buy any. And there weren't any purchases to give us comfort, over the last year. But since Quick Heal Technologies is profitable and growing, we're not too worried by this. The company boasts high insider ownership, but we're a little hesitant, given the history of share sales. While we like knowing what's going on with the insider's ownership and transactions, we make sure to also consider what risks are facing a stock before making any investment decision. For example - Quick Heal Technologies has 2 warning signs we think you should be aware of.

If you would prefer to check out another company -- one with potentially superior financials -- then do not miss this free list of interesting companies, that have HIGH return on equity and low debt.

For the purposes of this article, insiders are those individuals who report their transactions to the relevant regulatory body. We currently account for open market transactions and private dispositions, but not derivative transactions.

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.